Acrobiosystems Co Ltd Class A 301080
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 301080 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 41.98
- Day Range
- CNY 40.50–41.61
- 52-Week Range
- CNY 33.00–74.00
- Bid/Ask
- CNY 40.72 / CNY 40.73
- Market Cap
- CNY 4.89 Bil
- Volume/Avg
- 2.9 Mil / 2.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 34.86
- Price/Sales
- 8.83
- Dividend Yield (Trailing)
- 3.68%
- Dividend Yield (Forward)
- 3.68%
- Total Yield
- 3.57%
Company Profile
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 597
- Website
- https://www.acrobiosystems.cn
Comparables
Valuation
|
Metric
|
301080
|
000504
|
688136
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.86 | — | — |
Price/Book Value | 1.86 | 9.96 | 2.35 |
Price/Sales | 8.83 | 19.00 | 2.88 |
Price/Cash Flow | 49.04 | 70.39 | — |
Price/Earnings
301080
000504
688136
Financial Strength
|
Metric
|
301080
|
000504
|
688136
|
|---|---|---|---|
Quick Ratio | 13.32 | 1.54 | 1.46 |
Current Ratio | 14.50 | 1.69 | 1.73 |
Interest Coverage | 32.07 | −5.24 | −2.35 |
Quick Ratio
301080
000504
688136
Profitability
|
Metric
|
301080
|
000504
|
688136
|
|---|---|---|---|
Return on Assets (Normalized) | 4.53% | −4.73% | −5.49% |
Return on Equity (Normalized) | 4.86% | −26.44% | −10.00% |
Return on Invested Capital (Normalized) | 2.83% | −10.83% | −5.12% |
Return on Assets
301080
000504
688136
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Txchspxvnk | Ntmk | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Nwpwhgvv | Xkzmfx | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Lxjjbyr | Tcncw | $107.6 Bil | |
MRNA
| Moderna Inc | Lbvyjtb | Mzbmb | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Kpglzkkx | Xxqt | $22.2 Bil | |
ARGX
| argenx SE ADR | Nbhrvrlzy | Dyhkm | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Tsgbtqqc | Yjclvj | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Khfdtpwf | Fnqmxp | $15.1 Bil | |
INCY
| Incyte Corp | Vrlryzjc | Gmnrns | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Cnnlwjxhmm | Dbzvtky | $12.7 Bil |